Cancer Genetics and Pharmacology: Advancing Precision Therapeutics
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Biochemistry, Molecular and Cellular Biology".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 1287
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer genetics stands at the forefront of oncology research, elucidating the molecular dynamics behind cancer development and progression. Recent breakthroughs in genomic technologies, together with a growing database on genetic anomalies, have been crucial in advancing our understanding and treatment of cancer. Despite these strides, challenges like tumor heterogeneity, therapy resistance, and application of genetic discoveries into effective clinical practices continue to pose significant hurdles.
This Research Topic aims to enhance and broaden our understanding of cancer genetics with a focus on its integration with pharmacology. It seeks to spur innovations in drug development, refine therapeutic methods, and advance the implementation of precise, genetics-driven treatment models. By tackling critical issues such as drug resistance and using genetic markers for customized treatment, it endeavors to move the field toward a more cohesive and targeted approach to cancer therapy.
To address the complexities of this field, we invite contributions that explore, but are not limited to, the following themes:
- Genetic Mutations and Cancer: Key drivers and their role in targeted therapy.
- Genomic Technologies: Impact of advanced tools like NGS and CRISPR-Cas9.
- Tumor Heterogeneity: Influence on treatment strategies and disease outcomes.
- Biomarkers and Diagnostics: Importance in early detection and therapeutic accuracy.
- Targeted Therapies: Development and hurdles in interventions informed by genetics.
- Immunogenomics: Genetic factors affecting immune evasion and immunotherapy.
- Epigenetic Modifications: Potential targets and pharmaceutical interventions.
- Pharmacogenomics and Personalized Medicine: Customizing treatments based on genetic profiles.
- Translational Research: Bridging genetic discoveries with clinical practice.
- Future Directions: Emerging therapies and strategic innovations in precision medicine.
Through a comprehensive evaluation, this Research Topic will deepen our understanding of cancer genetics' foundation, paving the way for revolutionary advancements in cancer treatment.
Dr. Baoming Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer genetics
- epigenetic modifications
- pharmacogenomics
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
